408 related articles for article (PubMed ID: 35971151)
21. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology
Wu B; Zhang Y; Yu Y; Zhong C; Lang Q; Liang Z; Lv C; Xu F; Tian Y
Front Cell Dev Biol; 2021; 9():796740. PubMed ID: 34977037
[TBL] [Abstract][Full Text] [Related]
23. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro.
van Erk MJ; Roepman P; van der Lende TR; Stierum RH; Aarts JM; van Bladeren PJ; van Ommen B
Eur J Nutr; 2005 Mar; 44(3):143-56. PubMed ID: 15309432
[TBL] [Abstract][Full Text] [Related]
24. To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
Sun Y; Xie W; Kang N; Yi J; Ruan X; Hu L; Zhao J; Zheng X; Wei S; Gao M
Dis Markers; 2022; 2022():9541080. PubMed ID: 36510497
[TBL] [Abstract][Full Text] [Related]
25. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.
Yan X; Qi M; Li P; Zhan Y; Shao H
Cell Biosci; 2017; 7():50. PubMed ID: 29034071
[TBL] [Abstract][Full Text] [Related]
26. Quercetin: A functional dietary flavonoid with potential chemo-preventive properties in colorectal cancer.
Darband SG; Kaviani M; Yousefi B; Sadighparvar S; Pakdel FG; Attari JA; Mohebbi I; Naderi S; Majidinia M
J Cell Physiol; 2018 Sep; 233(9):6544-6560. PubMed ID: 29663361
[TBL] [Abstract][Full Text] [Related]
27. Network Pharmacology and in vitro Experimental Verification on Intervention of Quercetin, Present in Chinese Medicine Yishen Qutong Granules, on Esophageal Cancer.
Li J; Chang JY; Jiang ZL; Yin YK; Chen JY; Jin W; Li H; Feng L
Chin J Integr Med; 2023 Mar; 29(3):233-243. PubMed ID: 36094770
[TBL] [Abstract][Full Text] [Related]
28. Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells.
Kedhari Sundaram M; Raina R; Afroze N; Bajbouj K; Hamad M; Haque S; Hussain A
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31366565
[TBL] [Abstract][Full Text] [Related]
29. Protective Effects of Pretreatment with Quercetin Against Lipopolysaccharide-Induced Apoptosis and the Inhibition of Osteoblast Differentiation via the MAPK and Wnt/β-Catenin Pathways in MC3T3-E1 Cells.
Guo C; Yang RJ; Jang K; Zhou XL; Liu YZ
Cell Physiol Biochem; 2017; 43(4):1547-1561. PubMed ID: 29035884
[TBL] [Abstract][Full Text] [Related]
30. Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements.
Sethi G; Rath P; Chauhan A; Ranjan A; Choudhary R; Ramniwas S; Sak K; Aggarwal D; Rani I; Tuli HS
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840034
[TBL] [Abstract][Full Text] [Related]
31. Quercetin as an anticancer agent: Focus on esophageal cancer.
Davoodvandi A; Shabani Varkani M; Clark CCT; Jafarnejad S
J Food Biochem; 2020 Sep; 44(9):e13374. PubMed ID: 32686158
[TBL] [Abstract][Full Text] [Related]
32. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
[TBL] [Abstract][Full Text] [Related]
33. Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway.
Han M; Song Y; Zhang X
Pharmacogn Mag; 2016 May; 12(Suppl 2):S237-44. PubMed ID: 27279714
[TBL] [Abstract][Full Text] [Related]
34. Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence.
Wong SK; Chin KY; Ima-Nirwana S
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899435
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as molecular targets of quercetin and its derivatives underlying their biological effects: A preclinical strategy.
Wang D; Sun-Waterhouse D; Li F; Xin L; Li D
Crit Rev Food Sci Nutr; 2019; 59(14):2189-2201. PubMed ID: 29446655
[TBL] [Abstract][Full Text] [Related]
36. Quercetin-3-methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways.
Zhao S; Jiang Y; Zhao J; Li H; Yin X; Wang Y; Xie Y; Chen X; Lu J; Dong Z; Liu K
Mol Carcinog; 2018 Nov; 57(11):1540-1552. PubMed ID: 30035335
[TBL] [Abstract][Full Text] [Related]
37. Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro.
Qian X; Bi QY; Wang ZN; Han F; Liu LM; Song LB; Li CY; Zhang AQ; Ji XM
J Ethnopharmacol; 2023 May; 307():116198. PubMed ID: 36690307
[TBL] [Abstract][Full Text] [Related]
38. Quercetin Synergistically Enhances the Anticancer Efficacy of Docetaxel through Induction of Apoptosis and Modulation of PI3K/AKT, MAPK/ERK, and JAK/STAT3 Signaling Pathways in MDA-MB-231 Breast Cancer Cell Line.
Safi A; Heidarian E; Ahmadi R
Int J Mol Cell Med; 2021; 10(1):11-22. PubMed ID: 34268250
[TBL] [Abstract][Full Text] [Related]
39. Exploring the Mechanism of Buyang Huanwu Decoction Alleviating Restenosis by Regulating VSMC Phenotype Switching and Proliferation by Network Pharmacology and Molecular Docking.
Chen X; Yu J; Lei H; Li L; Liu X; Liu B; Xie Y; Fang H
Curr Comput Aided Drug Des; 2023; 19(6):451-464. PubMed ID: 36740793
[TBL] [Abstract][Full Text] [Related]
40. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
